$535 Million is the total value of Eagle Health Investments LP's 27 reported holdings in Q2 2023. The portfolio turnover from Q1 2023 to Q2 2023 was 33.3% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| IQV | Sell | IQVIA HLDGS INC | $49,335,891 | +9.5% | 219,495 | -3.1% | 9.22% | +5.2% |
| ILMN | Sell | ILLUMINA INC | $30,992,097 | -35.8% | 165,300 | -20.3% | 5.80% | -38.3% |
| ISRG | Sell | INTUITIVE SURGICAL INC | $29,847,943 | -18.3% | 87,290 | -39.0% | 5.58% | -21.6% |
| NTRA | Sell | NATERA INC | $28,986,470 | -33.5% | 595,694 | -24.1% | 5.42% | -36.1% |
| INSP | Sell | INSPIRE MED SYS INC | $23,647,752 | -0.5% | 72,843 | -28.3% | 4.42% | -4.5% |
| LNTH | Sell | LANTHEUS HLDGS INC | $21,248,544 | -9.6% | 253,200 | -11.1% | 3.97% | -13.2% |
| DXCM | Sell | DEXCOM INC | $20,870,024 | -22.4% | 162,400 | -29.9% | 3.90% | -25.5% |
| GH | Sell | GUARDANT HEALTH INC | $15,936,764 | +14.0% | 445,161 | -25.4% | 2.98% | +9.5% |
| SRPT | Sell | SAREPTA THERAPEUTICS INC | $11,147,377 | -41.7% | 97,340 | -29.8% | 2.08% | -44.0% |
| TNDM | Sell | TANDEM DIABETES CARE INC | $7,860,776 | -54.5% | 320,325 | -24.7% | 1.47% | -56.3% |
| LYEL | Exit | LYELL IMMUNOPHARMA INC | $0 | – | -100,000 | -100.0% | -0.05% | – |
| BCYC | Exit | BICYCLE THERAPEUTICS PLCsponsored ads | $0 | – | -23,500 | -100.0% | -0.10% | – |
| BEAM | Exit | BEAM THERAPEUTICS INC | $0 | – | -28,900 | -100.0% | -0.17% | – |
| OLK | Exit | OLINK HLDG ABsponsored ads | $0 | – | -40,000 | -100.0% | -0.18% | – |
| SGEN | Exit | SEAGEN INC | $0 | – | -174,902 | -100.0% | -6.89% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-08-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| IQVIA HLDGS INC | 12 | Q3 2023 | 9.6% |
| UNITED THERAPEUTICS CORP DEL | 12 | Q3 2023 | 8.7% |
| ALNYLAM PHARMACEUTICALS INC | 12 | Q3 2023 | 8.5% |
| NATERA INC | 12 | Q3 2023 | 8.5% |
| ARGENX SE | 12 | Q3 2023 | 7.0% |
| DEXCOM INC | 12 | Q3 2023 | 5.7% |
| OUTSET MED INC | 12 | Q3 2023 | 7.3% |
| AGIOS PHARMACEUTICALS INC | 12 | Q3 2023 | 7.2% |
| ADAPTIVE BIOTECHNOLOGIES COR | 12 | Q3 2023 | 5.1% |
| GUARDANT HEALTH INC | 12 | Q3 2023 | 3.8% |
View Eagle Health Investments LP's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-05-14 |
| 13F-HR | 2024-02-12 |
| 13F-HR | 2023-10-27 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-12 |
| 13F-HR | 2023-02-13 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-11 |
| 13F-HR | 2022-05-12 |
| 13F-HR | 2022-02-10 |
View Eagle Health Investments LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.